Reckitt Benckiser beats expectations thanks to bumper sales of healthcare brands April 24, 2015 The figures Consumer goods giant Reckitt Benckiser (RB) has reported a five per cent rise in like-for-like sales, which hit £2.2bn during the first quarter. Health and hygiene enjoyed strong growth, with net revenue rising by 32 per cent and 42 per cent respectively in those categories. Why it's interesting A bad flu season (bad [...]
Reckitt Benckiser to slash costs ahead of a difficult year February 11, 2015 Reckitt Benckiser has embarked on a major cost saving drive after the maker of Durex condoms and Dettol cleaning products beat market expectations with a four per cent jump in full-year sales. Chief executive Rakesh Kapoor said the efficiency plan, dubbed Project Supercharge, aims to deliver up to £150m in savings a year by 2017 [...]
Reckitt Benckiser fined half a million for market disclosure failing January 20, 2015 Consumer goods giant Reckitt Benckiser (RB) has been fined more than half a million pounds after failing to make a disclosure to markets correctly. The Financial Conduct Authority (FCA) handed out a penalty of £539,800 for “inadequate systems and controls to monitor share-dealing by its senior executives in its own shares” to the maker of [...]
Durex owner Reckitt Benckiser’s KY bid for lubricant-maker slips on antitrust probe January 7, 2015 Reckitt Benckiser’s bid for personal lubricant-maker KY came unstuck yesterday as regulators ordered a full competition investigation. The combined group owns the Durex and KY brands worldwide, but is awaiting regulatory approval in the UK. The Competition and Markets Authority (CMA) worries it will gain it an unduely dominant position in the market by owning [...]
Indivior IPO: Reckitt Benckiser splits off addiction unit November 17, 2014 Addiction treatment firm Indivior is set to join the FTSE100 as parent Reckitt Benckiser yesterday said it would float the business as a separate entity. However, the drug business may not remain listed in London for long – 80 per cent of its revenues come from the US, and its chief executive Shaun Thaxter expects [...]
Reckitt to float pharmaceutials arm in London July 28, 2014 Reckitt Benckiser, the owner of Nurofen painkillers and Dettol cleaning products, is to spin-off its pharmaceuticals business as it focuses on growing its core consumer brands. The FTSE 100 company said yesterday that a demerger of its RBP unit would take place over the next 12 months with a separate listing on the London Stock [...]
Reckitt Benckiser share price up on pharmaceutical business spin off July 28, 2014 Reckitt Benckiser’s share price opened almost two per cent higher this morning, up by more than three per cent at its peak, after announcing it will spin off its pharmaceutical business into a separately listed company over the next 12 months. The maker of household brands such as Nurofen confirmed the move which has been [...]
Shareholders revolt over pay at Reckitt and Ocado May 7, 2014 OCADO and Reckitt Benckiser have become the latest companies to suffer an investor backlash over pay for the most senior staff. About 20 per cent of investors in the online grocer voted against the remuneration report while 13 per cent opposed Ocado’s pay policy. A person familiar with the situation said Ocado’s board had consulted [...]
Reckitt hints at spinning off its drugs business April 16, 2014 RECKITT Benckiser signalled yesterday that it is leaning towards a spin-off of its troubled pharmaceuticals arm as it posted a better-than-expected rise in fourth quarter sales. The consumer goods group behind Durex condoms and Dettol cleaning products last year launched a strategic review of its RBP unit, which is focused on the drug Suboxone used [...]
Reckitt shares slide up after K-Y acquisition March 10, 2014 RECKITT Benckiser, the consumer conglomerate behind Nurofen painkiller and Durex condoms, has expanded into lubricants after buying the global rights to K-Y from Johnson & Johnson yesterday. Shares in the firm defied a tumbling FTSE 100 yesterday to close up 0.3 per cent. Reckitt, which did not disclose the price of the deal, said K-Y [...]